Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies | Biomarker Research | Full Text
Evaluating CD19 CAR expression levels
Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia | Nature Immunology
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Anti-human CD3/CD19 bispecific antibody | InvivoGen
Next-IO™ CD22 × CD19 Therapeutic CAR-T Program - Creative Biolabs
A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking | eLife
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia - Weiland - 2015 - Pediatric Blood & Cancer - Wiley Online Library
Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients | ACS Synthetic Biology
Good to know 05 | Gustave Roussy
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
CD19-directed chimeric antigen receptor (CAR) T cell | Research | BMS Science | HCP Site
JCI Insight - A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases
When CAR T cell therapy crashes
Buy Untouched Human Normal Peripheral Blood CD19+ B Cells (Untouched - neg – HumanCells Bio
CD19 - an overview | ScienceDirect Topics
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor: Molecular Therapy - Oncolytics
CD19 : une cible thérapeutique validée pour les tats malins à lymphocytes B - ACROBiosystems
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
CD19 - IHC Primary Antibodies-FR
Expression of CD19 and CD20 according to maturation steps. CD19 is... | Download Scientific Diagram
Human T Cells Expressing a CD19 CAR-T Receptor Provide Insights into Mechanisms of Human CD19-Positive β Cell Destruction - ScienceDirect
